Internally coated endotracheal tubes with silver sulfadiazine in polyurethane to prevent bacterial colonization: a clinical trial

[1]  Mauricio Valencia,et al.  Ventilator-associated pneumonia , 2009, Current opinion in critical care.

[2]  A. Baccarelli,et al.  Antimicrobial-coated endotracheal tubes: an experimental study , 2008, Intensive Care Medicine.

[3]  J. Rello,et al.  Reduced burden of bacterial airway colonization with a novel silver-coated endotracheal tube in a randomized multiple-center feasibility study* , 2006, Critical care medicine.

[4]  A. Zanella,et al.  The Mucus Slurper: a novel tracheal tube that requires no tracheal tube suctioning. A preliminary report , 2006, Intensive Care Medicine.

[5]  A. Baccarelli,et al.  Antibacterial-coated tracheal tubes cleaned with the Mucus Shaver , 2006, Intensive Care Medicine.

[6]  T. Wilt,et al.  Systematic Review: Antimicrobial Urinary Catheters To Prevent Catheter-Associated Urinary Tract Infection in Hospitalized Patients , 2006, Annals of Internal Medicine.

[7]  R. Pizov.  Endotracheal Tubes Coated With Antiseptics Decrease Bacterial Colonization of the Ventilator Circuits, Lungs, and Endotracheal Tube , 2005 .

[8]  A. Baccarelli,et al.  Endotracheal Tubes Coated with Antiseptics Decrease Bacterial Colonization of the Ventilator Circuits, Lungs, and Endotracheal Tube , 2004, Anesthesiology.

[9]  Nnis System.  National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. , 2003, American journal of infection control.

[10]  Christopher Post,et al.  The application of biofilm science to the study and control of chronic bacterial infections. , 2003, The Journal of clinical investigation.

[11]  R. Lazova,et al.  Scar-localized argyria secondary to silver sulfadiazine cream. , 2003, Journal of the American Academy of Dermatology.

[12]  A. Eldad,et al.  Silver-sulfadiazine eschar pigmentation mimics invasive wound infection: a case report. , 2003, The Journal of burn care & rehabilitation.

[13]  A. Baccarelli,et al.  New approaches for the prevention of airway infection in ventilated patients. Lessons learned from laboratory animal studies at the National Institutes of Health. , 2003, Minerva anestesiologica.

[14]  R. D. McCormick,et al.  Guidelines for the prevention of intravascular catheter-related infections. , 2002, Infection control and hospital epidemiology.

[15]  G. Rubenfeld,et al.  Statement of the 4th International Consensus Conference in Critical Care on ICU-Acquired Pneumonia – Chicago, Illinois, May 2002 , 2002, Intensive Care Medicine.

[16]  P. Lascombes,et al.  [Topic silver sulfadiazine bicytopenia: first case]. , 2002, Therapie.

[17]  L. Brochard,et al.  Association of noninvasive ventilation with nosocomial infections and survival in critically ill patients. , 2000, JAMA.

[18]  David S. Jones,et al.  Implications of endotracheal tube biofilm for ventilator-associated pneumonia , 1999, Intensive Care Medicine.

[19]  M. Hanumadass,et al.  Silver sulfadiazine induced Clostridium difficile toxic megacolon in a burn patient: case report. , 1998, Burns : journal of the International Society for Burn Injuries.

[20]  J. Viala,et al.  Agranulocytose après application de sulfadiazine argentique chez un nourrisson de 2 mois , 1997 .

[21]  L. Brochard,et al.  Gradual Reduction of Endotracheal Tube Diameter during Mechanical Ventilation via Different Humidification Devices , 1996, Anesthesiology.

[22]  J. Vincent,et al.  The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. , 1995, JAMA.

[23]  B. Latenser,et al.  Serious silver sulphadiazine and mafenide acetate dermatitis. , 1995, Burns : journal of the International Society for Burn Injuries.

[24]  D. Illingworth,et al.  Apolipoprotein ∈4 and coronary artery disease , 1992, The Lancet.

[25]  C. Bladin,et al.  Argyria from excessive use of topical silver sulphadiazine , 1992, The Lancet.

[26]  A. Fraser-Moodie.  Sensitivity to silver in a patient treated with silver sulphadiazine (Flamazine). , 1992, Burns : journal of the International Society for Burn Injuries.

[27]  A. Eldad,et al.  Silver sulphadiazine-induced haemolytic anaemia in a glucose-6-phosphate dehydrogenase-deficient burn patient. , 1991, Burns : journal of the International Society for Burn Injuries.

[28]  M. Hemmer.  Nosocomial pulmonary infections , 1990 .

[29]  T. Inglis,et al.  Tracheal tube biofilm as a source of bacterial colonization of the lung , 1989, Journal of clinical microbiology.

[30]  P. Thomson,et al.  Leukopenia in acute thermal injury: evidence against topical silver sulfadiazine as the causative agent. , 1989, The Journal of burn care & rehabilitation.

[31]  P. Engler,et al.  Leukopenia in non-septic burn patients receiving topical 1% silver sulfadiazine cream therapy: a survey. , 1988, The Journal of burn care & rehabilitation.

[32]  W. Marshall,et al.  Leukopenia secondary to silver sulfadiazine: frequency, characteristics and clinical consequences. , 1987, The American surgeon.

[33]  J. N. Bleicher,et al.  Transient leukopenia associated with topical silver sulfadiazine in burn therapy. , 1987, The Nebraska medical journal.

[34]  P. Raine,et al.  Topical silver sulphadiazine and profound neutropenia in a burned child. , 1986, Burns, including thermal injury.

[35]  N. Shear,et al.  Hyperpigmentation due to topical application of silver sulfadiazine cream. , 1985, Journal of the American Academy of Dermatology.

[36]  D. Prough,et al.  Nosocomial pulmonary infection: Possible etiologic significance of bacterial adhesion to endotracheal tubes , 1985, Critical care medicine.

[37]  P. Raine,et al.  Topical silver sulphadiazine: side effects and urinary excretion. , 1983, Burns, including thermal injury.

[38]  E. Constant,et al.  Leukopenia secondary to sulfadiazine silver , 1980, JAMA.

[39]  R. Demling,et al.  Acute leukopenia during topical burn therapy with silver sulfadiazine. , 1978, American journal of surgery.

[40]  H. F. Carvajal,et al.  A controlled study of the effects of silver sulfadiazine on white blood cell counts in burned children. , 1977, The Journal of trauma.

[41]  National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. , 2004, American journal of infection control.

[42]  D. Kovacevich,et al.  Guidelines for the prevention of intravascular catheter-related infections: Centers for Disease Control and Prevention. , 2003, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[43]  Jia Xm.  Hypersensitivity due to topical use of silver sulfadiazine on burn wounds (report of 6 cases) , 1985 .

[44]  X. Jia.  [Hypersensitivity due to topical use of silver sulfadiazine on burn wounds (report of 6 cases)]. , 1985, Zhonghua zheng xing shao shang wai ke za zhi = Zhonghua zheng xing shao shang waikf [i.e. waike] zazhi = Chinese journal of plastic surgery and burns.

[45]  S. Hoffmann,et al.  Silver sulfadiazine: an antibacterial agent for topical use in burns. A review of the literature. , 1984, Scandinavian journal of plastic and reconstructive surgery.